LE NOSTRE PUBBLICAZIONI
ONCOLOGY REASEARCH 2026
L’articolo “Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival”
COLTONE STUDY 2023
L’articolo “Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study“.
A pagina 6 i ringraziamenti al Deportivo Peccioli, a pagina 7 il riferimento alla Fondazione Faro.
BREAST CANCER 2022
L’articolo “A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients” pubblicato sulla rivista Breast Cancer.
PHARMACOGENOMICS 2014
L’articolo “Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms inadvanced breast cancer patients treated with paclitaxel and bevacizumab“, frutto del progetto Bevapros e pubblicato nel 2014 sulla rivista Pharmacogenomics.
ANGIOGENESIS 2012
L’articolo “Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers“, pubblicato sulla rivista Angiogenesis nel 2012.
